Parkinson-plus syndrome

Epidemiology Forecast Multiple System Atrophy (MSA) to 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, February 12, 2021
Biotechnology, Pharmaceutical, Health, Other Health, Neurological disorders, Nervous system, Rare diseases, Multiple system atrophy, MSA, Parkinson-plus syndrome

The "Multiple System Atrophy (MSA) - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Multiple System Atrophy (MSA) - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • Multiple System Atrophy (MSA), formerly known as Shy-Drager Syndrome, is a rare, degenerative neurological disorder affecting the body's involuntary (autonomic) functions, including blood pressure, breathing, bladder function, and motor control.
  • The term multiple system atrophy was first introduced in the medical literature in 1969.
  • The MSA epidemiology model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies.